Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-30 @ 12:30 PM
Study NCT ID:
NCT00446134
Status:
COMPLETED
Last Update Posted:
2012-07-27
First Post:
2007-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)
Sponsor:
Bausch Health Americas, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-08
First Submit QC Date:
None
Study First Post Date:
2007-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-20
Results First Submit QC Date:
None
Results First Post Date:
2012-07-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-20
Last Update Post Date:
2012-07-27
Last Update Post Date Type:
ESTIMATED